Bio-Rad Laboratories | BIO - 税前利润



金融业
股票价格
USD
资产
USD 10.58B
现金及等价物
USD 529.8M
销售成本
USD 309.6M
流动资产
USD 2.91B
流动负债
USD 517M
债务
USD 1.4B
EBIT
USD -418.8M
EBITDA
USD -374.6M
员工
8.03K
EPS每股收益
USD 2.51
股本和储备
USD 7.45B
销售毛利
USD 343.4M
债务利息支出
USD 12.3M
利息收入
USD 13.7M
贷款资金
USD 1.2B
市值
USD 6.39B
净收入
USD -341.9M
营业费用
USD 6.74B
营业利润
USD 63.9M
普通股股本
USD 26.97M
PE价格收益
16.42
税前利润
USD 82.9M
销售收入
USD 693.2M
销售和管理费用
USD 206.8M
股票
USD 740.7M
贸易债权人
USD 129M
应收帐款人
USD 464.7M


税前利润 更改 日
Abbott USD 2.39B 27M 2026-03
Agilent USD 442M 1000K 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio Techne USD 84.99M 107.85M 2025-09
Bio-Rad Laboratories USD 82.9M 331.1M 2025-09
Bruker USD -72.6M 73.1M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.24B 138M 2026-03
General Electric Aerospace USD 2.2B 654M 2026-03
Illumina USD 220M 86M 2025-09
IQVIA Holdings USD 537M 5.62B 2025-12
Laboratory Of America USD 337M 32.3M 2025-09
Merck USD 6.74B 22M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Siemens EUR 2.39B 505M 2025-09
Standard Biotools USD -22.03M 10.87M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tosoh JPY 30.93B 18.15B 2025-12
Waters USD 170.12M 7.57M 2025-09